Ardelyx, ordinary share
ARDX, US0396971071

• 11/08/2026
  Ardelyx: Other Events
• 19/02/2026
  Ardelyx: , Including Exhibit 99.1 Hereto, Shall Not Be Considered “filed” Under The Securities Exchange Act Of 1934, As Amended (the “exchange Act”), Nor Shall It Be Incorporated By Reference Into Any Future Filing Under The Securities Act Of 1933, As Amended (the “securities Act”), Or Underthe Exchange Act, Unless The Company Expressly Sets Forth In Such Future Filing That Such Information Is To Be Considered “filed” Or Incorporated By Reference Therein, Regulation Fd Disclosure, Financial Statements And Exhibits
• 09/01/2026
  Ardelyx, Inc. (NASDAQ:ARDX) Receives "Strong Buy" Rating from Raymond James
• 08/01/2026
  Ardelyx: Is Incorporated Into This Item 8.01 By Reference, Financial Statements And Exhibits
• 03/01/2026
  Raymond James Reaffirms Strong Buy on Ardelyx After Drug Price Increases
• 01/08/2025
  Ardelyx: Shall Not Be Considered “filed” Under The Securities Exchange Act Of 1934, As Amended, Nor Shall It Be Incorporated By Reference Into Any Future Filing Under The Securities Act Of 1933, As Amended, Or Underthe Securities Exchange Act Of 1934, As Amended, Unless The Company Expressly Sets Forth In Such Future Filing That Such Information Is To Be Considered “filed” Or Incorporated By Reference Therein, Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers; Compensatory Arrangements Of Certain Officers, Amendments To Articles Of Incorporation Or Bylaws; Change In Fiscal Year, Financial Statements And Exhibits
• 30/06/2025
  Ardelyx: Entry Into A Material Definitive Agreement, Financial Statements And Exhibits
• 18/06/2025
  Ardelyx: Submission Of Matters To A Vote Of Security Holders, Financial Statements And Exhibits